Loading people...
Joseph Siletto is the Co-Managing Partner of Life Sciences Private Capital at J.P. Morgan Private Capital, based in Boston. With over 25 years of healthcare investing experience, he previously served as a Managing Director at Vivo Capital and worked as an investment banker at Bank of America Securities and Cowen Inc. As an operator, he co-founded and served as CEO of Scion Medical Technologies, a medical device company acquired by Varian Medical in 2019. During his tenure at Vivo Capital, he directed investments across more than 10 portfolio companies and facilitated notable exits, including the January 2021 acquisition of Preventice Solutions by Boston Scientific. Holding an MBA from UC Berkeley and a bachelor's degree from Duke University, his current focus is executing Series B through pre-IPO growth equity investments across the life sciences sector.
Joseph Siletto is a distinguished Managing Director at Vivo Capital, a leading global healthcare investment firm renowned for its focus on biotechnology, pharmaceuticals, and medical technology. In his pivotal role, Mr. Siletto is responsible for sourcing, evaluating, and executing new investment opportunities, as well as providing strategic oversight to Vivo Capital's diverse portfolio companies. His deep understanding of the healthcare landscape and keen financial acumen make him a key figure in the firm's mission to support groundbreaking advancements in life sciences.
Mr. Siletto's investment focus at Vivo Capital spans a broad spectrum of the healthcare industry. He actively seeks out companies poised for significant growth in areas such as novel therapeutics, innovative medical devices, diagnostics, and digital health solutions. His approach involves identifying firms with strong scientific foundations, compelling market opportunities, and robust management teams. Joseph Siletto is committed to investing in companies that not only promise substantial financial returns but also have the potential to deliver transformative patient outcomes and address unmet medical needs globally.
Prior to his tenure at Vivo Capital, Joseph Siletto built a strong foundation in finance and strategic analysis, equipping him with the expertise necessary to navigate the complexities of healthcare investing. His background likely includes significant experience in investment banking, private equity, or venture capital, where he honed his skills in financial modeling, due diligence, and deal structuring. This extensive experience has enabled him to develop a comprehensive understanding of market dynamics, regulatory environments, and technological trends within the life sciences sector. His career trajectory reflects a consistent dedication to identifying and nurturing high-potential ventures.
Throughout his career at Vivo Capital, Joseph Siletto has been instrumental in a number of successful investments that have contributed significantly to the firm's impressive track record. While specific deal details are often confidential, his contributions have helped guide numerous portfolio companies through critical growth phases, including product development, market expansion, and successful exits. These achievements underscore his ability to identify promising enterprises and provide the strategic guidance needed to unlock their full potential. Joseph Siletto's work at Vivo Capital continues to reinforce the firm's position as a premier investor in the global healthcare ecosystem, driving innovation and value creation.
Joseph Siletto is a Managing Director at Vivo Capital, a leading global healthcare investment firm. He specializes in identifying and executing strategic investments across the life sciences sector.
Joseph Siletto invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions, through his role at Vivo Capital.
Joseph Siletto works as a Managing Director at Vivo Capital, a prominent investment firm focused on the global healthcare industry.
